Displaying drugs 5401 - 5425 of 11558 in total
2-aminoisobutyric acid
Experimental
Acid yellow 54 free acid
Experimental
Ambroxol acefyllinate
Experimental
Investigational
Ferulic acid
Experimental
Matched Categories: … Compounds used in a research, industrial, or household setting …
Zoptarelin doxorubicin
Zoptarelin doxorubicin has been used in trials studying the treatment of Breast Cancer, Ovarian Cancer, Prostate Cancer, Endometrial Cancer, and Urothelial Carcinoma, among others.
Investigational
ALKS 27
ALKS 27 is an inhaled formulation of trospium chloride for the treatment of chronic obstructive pulmonary disease (COPD). Study showed that ALKS 27 was well-tolerated over a wide dose range, with no dose-limited effects observed.
Investigational
Matched Description: … Study showed that ALKS 27 was well-tolerated over a wide dose range, with no dose-limited effects observed …
ATX-101
ATX-101 (medical), sodium deoxycholate for subcutaneous injection, is being evaluated as a treatment for the reduction of localized fat deposits. This includes treatment of superficial lipomas (benign tumors of soft tissue composed of mature fat cells), fat deposits in the submental region of the face/neck, and localized fat deposits in...
Investigational
Matched Description: … As a naturally occurring component of the human body, deoxycholate is considered a ‘biocompatible’ detergent ... ATX-101 demonstrates a relative selectivity for fat over other tissues. ... ATX-101 (medical), sodium deoxycholate for subcutaneous injection, is being evaluated as a treatment …
AME-527
AME-527 is a humanized monoclonal antibody that recognizes human TNF-alpha (hTNF-alpha) with high affinity and specificity. AME-527 was generated by protein engineering and identified from a library of antibody variants based on its improved binding properties.
Investigational
Matched Description: … AME-527 is a humanized monoclonal antibody that recognizes human TNF-alpha (hTNF-alpha) with high affinity ... AME-527 was generated by protein engineering and identified from a library of antibody variants based …
ABX-PTH
ABX-PTH is a fully human monoclonal antibody generated by Abgenix's technology platform. This drug targets and neutralizes the action of parathyroid hormone (PTH) for the treatment of a secondary hyperparathyroidism.
Investigational
Matched Description: … ABX-PTH is a fully human monoclonal antibody generated by Abgenix's technology platform. ... This drug targets and neutralizes the action of parathyroid hormone (PTH) for the treatment of a secondary …
AT-7519
AT7519 is a selective inhibitor of certain Cyclin Dependent Kinases (CDKs) leading to tumour regression. It is developed by Astex for the treatment of solid tumours and haematological malignancies.
Investigational
Matched Description: … AT7519 is a selective inhibitor of certain Cyclin Dependent Kinases (CDKs) leading to tumour regression …
ADP-597
JNJ-38431055 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
Investigational
ABT-384
ABT-384 has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
AEE-788
AEE788 has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Brain and Central Nervous System Tumors.
Investigational
AMY-101
AMY-101, also known as compstatin 40, is a peptidic inhibitor of the central complement component C3. AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis).
Investigational
Matched Description: … AMY-101, also known as compstatin 40, is a peptidic inhibitor of the central complement component C3. ... AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor …
ABT-072
ABT-072 is under investigation in clinical trial NCT00890318 (A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C).
Investigational
Matched Description: … ABT-072 is under investigation in clinical trial NCT00890318 (A Study in Healthy Adult Subjects to Evaluate …
ABT-288
ABT-288 is under investigation in clinical trial NCT01018875 (Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease).
Investigational
AMP-224
Investigational
ABO-202
Investigational
ACT-101
ACT-101 is a recombinant human alpha-fetoprotein or rhAFP.
Investigational
Matched Description: … ACT-101 is a recombinant human alpha-fetoprotein or rhAFP. …
AVI-014
AVI-014 is a glycosylated, recombinant human granulocyte colony-stimulating factor (G-CSF).
Investigational
Matched Description: … AVI-014 is a glycosylated, recombinant human granulocyte colony-stimulating factor (G-CSF). …
AB-8939
Investigational
ADH-503
Investigational
Displaying drugs 5401 - 5425 of 11558 in total